Literature DB >> 31281616

A New Method for Biostatistical miRNA Pattern Recognition with Topological Properties of Visibility Graphs in 3D Space.

Matej Babič1, Ninoslav Marina2, Andrej Mrvar3, Kumar Dookhitram4, Michele Calì5.   

Abstract

Visibility is a very important topic in computer graphics and especially in calculations of global illumination. Visibility determination, the process of deciding which surface can be seen from a certain point, has also problematic applications in biomedical engineering. The problem of visibility computation with mathematical tools can be presented as a visibility network. Instead of utilizing a 2D visibility network or graphs whose construction is well known, in this paper, a new method for the construction of 3D visibility graphs will be proposed. Drawing graphs as nodes connected by links in a 3D space is visually compelling but computationally difficult. Thus, the construction of 3D visibility graphs is highly complex and requires professional computers or supercomputers. A new method for optimizing the algorithm visibility network in a 3D space and a new method for quantifying the complexity of a network in DNA pattern recognition in biomedical engineering have been developed. Statistical methods have been used to calculate the topological properties of a visibility graph in pattern recognition. A new n-hyper hybrid method is also used for combining an intelligent neural network system for DNA pattern recognition with the topological properties of visibility networks of a 3D space and for evaluating its prospective use in the prediction of cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31281616      PMCID: PMC6594254          DOI: 10.1155/2019/4373760

Source DB:  PubMed          Journal:  J Healthc Eng        ISSN: 2040-2295            Impact factor:   2.682


1. Introduction

Manufacturing the visibility network (graph) [1] is a fundamental geometric structure which has useful applications in several fields including illumination and rendering, motion planning, pattern recognition, and sensor networks. A graph G is called a visibility graph when there is a polygon P such that the vertices of P are the vertices of G and two vertices are adjacent in G if they are visible in P. A visibility graph can be used in spatial analysis of urban and building spaces and applied to landscapes, as well. It is formed by taking a set of points across the space and forming graph edges between those points, if they are mutually visible. Visibility graphs have been widely used for 2D applications so far, but in this paper, an application to complex 3D visibility problems is advanced. Visibility calculations are central to any computer graphics application. The relevance of statistics [2] has been much more recognized in the biomedical engineering field. Statistics can provide technicians of laboratories with important instruments for a scientific analysis of biomedical phenomena, allowing to understand the observed phenomena more correctly and to obtain more reliable results. Biomedical engineering [3] being one of the fastest growing engineering disciplines aims at applying engineering expertise and advances to the field of medical needs and bioscience for the enhancement of healthcare. Deoxyribonucleic acid (DNA) pattern recognition constitutes one of the most important works in biomedical engineering. Pattern recognition [4] is a branch of machine learning that focuses on the recognition of patterns and regularities in data, although it is in considered to be in some cases nearly synonymous with machine learning. In pattern recognition, labels are assigned to objects and all objects are described by features, also called attributes. A classic example is the recognition of handwritten digits for the purpose of automatic mail sorting. Pattern recognition methods based on machine learning techniques [5] have been shown to be a promising approach to the analysis of network data. Intelligent computing has attracted many scientists and researchers working on intelligent techniques for solving complex real-world problems. The graphical representations of the DNA as a method for DNA pattern recognition have been introduced to facilitate comparison of DNA sequences and to observe differences in their structure [6-10]. A novel method is thus explored in this study to generate and characterize complex networks by means of analysis of their miRNA sequences. A new hybrid method [11] that combines three types of intelligent neural network systems [12] has been used. This paper explores the use of an intelligent system [13] with a new hybrid method that improves the existing ones. It is based on the n-hyper hybrid method. The aim of this work is to outline possibilities for applying an n-hyper hybrid system method for miRNA pattern recognition [14] with topological properties of visibility graphs in a 3D space and to evaluate its prospective use in biomedical engineering. The proposed method can be utilized to approach more systematically problems of visibility of miRNA sequences, in the comparison of DNA sequences and in the analysis of complex networks such as miRNA networks in the biomedical field. The method is based on an algorithm which is built for optimizing the visibility in a 3D space and an n-hyper hybrid system for miRNA cancer pattern recognition which allows to register more precisely the risk of various types of cancer. In particular, the proposed method can be used to analyze the transformation of 1D miRNA sequences into 3D miRNA sequences for predicting cancer. More specifically, a new type of intelligent system, the n-hyper hybrid system, has been developed to describe miRNA sequences and the difference between cancer and noncancer miRNA. Thanks to this method, some more information on a complex network derived from the visibility network in a 3D space, compared to the visibility graph, can be obtained in the application of miRNA pattern recognition. The utility of applying 3D visibility graphs in biomedical engineering for a more precise prediction of cancer will be thus discussed in this paper. Finally, this new method permits to obtain a physical visualization of the three-dimensional miRNA sequences. Through additively manufactured (3D printing) techniques, which are much used in the biomedical field for building and analysis of implantable devices [15-18], it is possible indeed to have a reconstruction of the 3D space network as a lattice structure as well as a view of the relationships between miRNA sequences. This paper is organized as follows: Section 2 is devoted to a description of the methods and the materials used. In Section 3, the results and discussions are illustrated. Final considerations and conclusions are drawn in Section 4.

2. Materials and Methods

2.1. A New Method for Statistical miRNA Pattern Recognition

DNA [19-23] is composed of an extremely long array of nucleotides. MicroRNAs [23-27] constitute a recently discovered class of noncoding RNAs playing some key roles in the regulation of gene expression. In this article, we have developed a new method to describe the transformation of 1D miRNA sequences into 3D miRNA sequences. This means that we have transformed the miRNA sequences into a 3D coordinate system. For better presentation, four colours are used to denote the nucleotides adenine (A), cytosine (C), guanine (G), and thymine (T). We have replaced each nucleotide by different colours, namely, A by white, C by light purple, G by gray, and T by black. Initially, we have transformed each nucleotide of the DNA sequences into a 2D array by using a spiral curve. Figure 1 presents the coloured miRNA sequences (miR-612 gene) and transformation of each nucleotide of the miRNA sequences into a 2D array by using a spiral curve. We have also denoted the miRNA sequences by two coordinates (x, y).
Figure 1

Coloured miRNA sequences (miR-612 gene) and transformation of each nucleotide of the DNA sequences into a 2D array by using a spiral curve.

Furthermore, we have denoted each nucleotide of the miRNA sequences with a number. An example of an miRNA sequence is … TGCCAATCGTTGT …. This sequence of letters can be converted with the function f. We have denoted {A, C, G, T} ∈ M and {1, 2, 3, 4} ∈ N. Also, f :M ⟶ N. We have denoted with nA, nC, nG, and nT the number of all nucleotides A, C, G, and T in some sequences. We have determined linear arrangement {nA, nC, nG, nT} from the largest to the smallest value. For example, if nA > nC > nG > nT, then we have function f, f : A ⟶ 4, f :C ⟶ 3, f : G ⟶ 2, and f : T ⟶ 1 or f(A) = 4, f(C) = 3, f(G) = 2, and f(T) = 1. When using function f, we can write f(… TGCCAATCGTTGT …) = … 1233441231121 …. Also, the function f denotes the third coordinate of the miRNA nucleotides in a 3D space, (x, y, z). In the third step, we have used a new method for optimizing the algorithm visibility graph in a 3D space (Figure 2).
Figure 2

Visibility graph of miRNA sequences (miR-612 gene).

For each visibility graph of the miRNA sequences, we have calculated the statistical property chi-square of triads [28]. If ν independent variables x are each normally distributed with mean µ and variance σ2, then the quantity known as chi-square (χ2) is denoted by

2.2. A New Method for Optimizing the Algorithm Visibility Graph in 3D Space

We have developed a new algorithm for the construction of visibility graphs in a 3D space [29]. Two arbitrary data values (x, y) and (x, y) will have visibility and will consequently become two connected nodes of the associated graph if any other data (x, y) placed between them fulfil the following relation [30]: We wanted to know how to connect the nodes in Figure 3. Nodes v and v of the 3D graph, where i < k and j < l, are connected by a link if and only if they are visible.
Figure 3

Visibility nodes (blue line) and unrelated nodes (red line).

This means that the path from v to v has no points on the graph. An example is presented in Figure 3, in which the nodnes connected by the blue line are visible to each other and those connected by the red line are an example of unrelated nodes (the straight line that connects the two nodes pierces the graph, which is contrary to the definition of the visibility graph). The following section describes how to construct a 3D visibility graph. The open problem of visibility graphs in a 2D space has thus been presented (Figure 4). Also, we have transformed all 3D points by perpendicular projection on the xy plane.
Figure 4

Solution of the 3D visibility graph presented as a 3D graph in a 3D space and in a 2D space.

As a first step, we have the 3D points which are transformed into a 2D plane. A graphical solution on a 5 × 5 grid is given because it provides a better visual representation. Figure 5 presents the nodes of the graph.
Figure 5

3D nodes which are transformed into a 2D plane.

In the second step, we have connected neighbouring nodes. Also, node T(x, y) is connected with nodes T(x, y), T(x, y), T(x, y), and T(x, y) if node T(x, y) is not located on the edge of a complex network. If node T(x, y) is on the edge of a complex network, then it is connected with two or three nodes only, as presented in Figure 6.
Figure 6

Neighbouring nodes.

In the third step, nodes T(x, y), T(x, y), T(x, y), and T(x, y, z) present quadrilaterals, and it is possible to see many quadrilaterals in Figure 7. In all quadrilaterals, nodes from a higher z coordinate are connected with other nodes by diagonal lines.
Figure 7

Nodes connected with other nodes by diagonal lines.

In the fourth step (Figure 8), we have broken the set of all nodes (x, y, z) into two sets. The first set presents all nodes (x, 0, z), and the second set presents all nodes (0, y, z). We have presented those nodes that are visible in the first set and those that are visible in the second set. In the first set, two nodes T(x, y, z) and T(x, y, z) are visible and will consequently become connected nodes on the associated graph if any other node T(x, 0, z) placed between them fulfils the following relation:
Figure 8

Fourth step of visibility graph creation.

In the second set, two nodes T(x, y, z) and T(x, y, z) are visible and will consequently become two connected nodes on the associated graph if any other node T0,(0, y, z0,) placed between them fulfils the following relation: In the fifth step, we have connected all other visible nodes. Two nodes T(x, y, z) and T(x, y, z) will be visible if no nodes exist on the line between T(x, y, z) and T(x, y, z). Figure 9 presents the solution of the 3D visibility graph on a 5 × 5 grid.
Figure 9

Solution of the 3D visibility graph on a 5 × 5 grid.

2.3. Optimizing the Algorithm Visibility Network in 3D Space

All 3D points transform into 2D points {(x, y, z) ⟶ (x, y)} Node T(x, y) is connected with nodes T(x, y), T(x, y), T(x, y), and T(x, y), if node T(x, y) is not located on the edge of a complex network If node T(x, y) is on the edge of a complex network, then it is connected with two or three nodes only Nodes from a higher z coordinate of all nodes T(x, y), T(x, y), T(x, y), and T(x, y, z) in quadrilaterals are connected with other nodes by diagonal lines Two nodes T(x, y, z) and T (x, y, z) are connected, if any other node T(x, 0, z) placed between them fulfils z < z + (z − z)(x − x)/(x − x) Two nodes T(x, y, z) and T(x, y, z) are connected, if any other node T0,(0, y, z0,) placed between them fulfils z < z + (z − z)(y − ym)/(y − y) Two nodes T(x, y, z) and T(x, y, z) are connected, if no nodes exist on the line between T(x, y, z) and T(x, y, z)

2.4. A New n-Hyper Hybrid Method

Hybrid evolutionary computation is a generic, flexible, robust, and versatile method for solving complex global optimization problems and can also be used in practical applications. Only three methods are adopted using intelligent systems, namely, the neural networks NN1 (present prediction with 33%; also, we use 67% of the data for the learning set and 33% for the test set), NN2 (present prediction with 50%; also, we use 50% of the data for the learning set and 50% for the test set), and NN3 (present leave-one-out cross-validation method). We have used a four-layer network with a learning rate of 0.7, moment of learning of 0.6, tolerance of test set of 0.02, and tolerance of learning set of 0.2. Hybrid 1 presents the sequence hybrid method. In this hybrid, methods are connected in series in the direction of the entrance to the method n. All methods work independently of the other methods. The results of input method 1 are transferred to input method 2, and the results of input method 2 are transferred to input method 3. Hybrid 2 presents the cyclic hybrid method. In Hybrid 2, methods are connected in series in the direction of the entrance to the method n. All methods work independently of the other methods. The results of input method 1 are transferred to input method 2, the results of input method 2 are transferred to input method 3, and the results of input method 3 are transferred to input method 1. In Hybrid 3, all methods work independently of the other methods. The results of input method 1 are transferred to input method 2, the results of input method 2 are transferred to input method 3, the results of input method 3 are transferred to input method 2, and the results of input method 2 are transferred to input method 1. 1-hyper hybrid methods are similar to hybrid methods. Also, we have repeated the process up to n, where n ∈ N. In the end, we have n-hyper hybrid methods. Figure 10 presents all the processes of building n-hyper hybrids.
Figure 10

n-Hyper hybrid method.

3. Results and Discussion

The visibility graph problem itself has long been studied in computational geometry and has been applied to a variety of areas. We present a new method for describing the transformation of 1D miRNA sequences into 3D miRNA sequences. We combine this method with a new method for optimizing the algorithm visibility graph in a 3D space. Based on the variation network, several topological properties, such as different types of triads, are calculated for natural miRNA sequences. Also, the correlations between types of triads over the variation network are obtained. It is well known that there is an individual cancer susceptibility despite equivalent environmental exposure, likely due to polymorphisms in genes involved in carcinogenesis. Table 1 presents a list of miRNA gene polymorphisms associated with cancer. We use the miR-146a, hsa-mir-149, hsa-mir-196a-2, hsa-mir-608, and hsa-miR-612 genes from the miRNA base. MiR-146a is a family of microRNA precursors found in mammals, including humans. MiR-146a is primarily involved in the regulation of inflammation and other processes that function in the innate immune system. Loss of functional miR-146a (and mir-145) could predispose an individual to suffer from chromosome 5q deletion syndrome. MiR-146 has also been reported to be highly upregulated in the osteoarthritis cartilage and could be involved in its pathogenesis. An increasing body of evidence points to a possible role of microRNAs (miRNAs) in hereditary cancer syndromes [31, 32].
Table 1

List of miRNA gene polymorphisms associated with cancer.

miRNA nameMarkrs numberNucleotide changeCancer type
hsa-mir-146aD12910164A>GIncreased risk for gastric cancer
hsa-mir-149D271428439A>GIncreased risk for chronic lymphocytic leukemia
hsa-mir-196a-2D311614913C>TBreast cancer
hsa-mir-608D44919510C>GIncreased risk for breast cancer
hsa-mir-612D512803915G>AB-cell acute lymphoblastic leukemia
Recently, variations of the miR-146a gene have drawn increasing attention in cancer etiologies, and altered expression levels have been observed in inflammatory diseases as well as in cancers [33, 34]. MicroRNA hsa-mir-149 is located on chromosome 2. It is an intronic miRNA and is located in sense orientation relative to its protein-coding host gene glypican 1 (GPC1). Our integrated review of miRNA-SNPs revealed that polymorphisms of hsa-mir-149 have previously been associated with increased or decreased risk of seven cancer types: renal cell carcinoma and breast, colorectal, gastric, hepatocellular, papillary, and thyroid cancers. miR149 rs71428439 predisposes its carriers to CCRCC, and miR149 rs71428439 may be a new biomarker for predicting the risk of CCRCC [35]. miR-196 appears to be a vertebrate-specific microRNA and has now been predicted or experimentally confirmed in a wide range of vertebrate species (MIPF0000031). The hairpin precursors are predicted based on base pairing and cross-species conservation—their extents are not known. Many studies demonstrated that the hsa-miR-196a2 rs11614913 SNP was significantly associated with the susceptibility of breast cancer [36-38]. MicroRNA hsa-mir-608 is located on chromosome 10. It is an intronic miRNA, located in sense orientation relative to its host gene semaphorin 4G (SEMA4G) and in antisense orientation to the mitochondrial ribosomal protein L43M (RPL43) gene. Several studies [39-46] examined the impact of miR-608 rs4919510C>G on the risk of various cancers, but the results were inconsistent. Additionally, it has also been associated with increased risk of breast, nasopharyngeal, and papillary thyroid carcinomas. MicroRNA hsa-mir-612 is located on chromosome 11. It is an exonic miRNA, located in sense orientation relative to its host gene, nuclear paraspeckle assembly transcript 1 (NEAT1). Polymorphism with pre-miRNA regions has been associated with B-cell acute lymphoblastic leukemia [47-49]. Also, we have used a new method for optimizing the algorithm visibility graph in a 3D space and a new method for miRNA cancer pattern recognition. We have determined the topological properties of the triad patterns, in miRNA networks [50]. The analysis of triads and the prevalence of different types of triads in populations has been a staple of most network analyses. The input data of neural networks are the topological properties, namely, the triads of miRNA patterns and function f of sequences of miRNA. The output data (Y) of the neural data decide whether the miRNA is associated with cancer: if the miRNA is not associated with cancer, then 1 is output, else 0 is output. Table 2 presents the topological properties of the visibility graphs in a 3D space of DNA patterns. D1–D5 present the mark of DNA. C1–C5 present cancer D1–D5 DNA. TP1–TP10 [51] present the types of topological properties of triads: TP1 presents type 1-102, TP2 presents type 1-003, TP3 presents type 2-012, TP4 presents type 6-021C, TP5 presents type 7-111D, and TP6 presents type 8-111U. For each constructed variation miRNA network, the related topological properties are shown in Table 2. We can see that triad TP1 type 1-102 increases for cancer miRNA (rows C1–C5). In the third column, we can see that triad TP3 type 2-012 decreases for cancer miRNA (rows C1–C5). In the fourth column, we can see that triad TP4 type 6-021C decreases for cancer miRNA (rows C1–C5). In the fifth column, we can see that triad TP6 type 8-111U decreases for cancer miRNA (rows C1–C5). Also, these three types of triads present a significant correlation between miRNA and cancer miRNA.
Table 2

Topological properties of the graph of miRNA patterns.

N TP1TP2TP3TP4TP5TP6 Y
D115359126096174844895055220
C115372126020174464865095251
D215511126406172404975144690
C215611126482170824905094701
D318875167586209474245305220
C318886167784207534215245251
D415601125597180934024884800
C415603125596180854014874811
D515611126952166574544934690
C515639126953166554534924731
Table 3 presents the statistical properties of the graph of miRNA patterns. X presents the modification of the nucleotide position. S1 presents the place number of changed nucleotides in miRNA. S2 presents the number of all edges in the graph. S3 presents the chi-square of triads. In hsa-mir-146a, nucleotide A changes into G on the 50th place, which is described in column S1. The chi-square of the triads increases on hsa-mir-149, hsa-mir-196a-2, and hsa-mir-608 in another decrease.
Table 3

Statistical properties of the graph of miRNA patterns.

N X S1S2S3
D1A50395251228
C1G50396249883
D2A83392265112
C2G83390269117
D3C78425365987
C3T78423368945
D4C37399265911
C4G37399266532
D5G51386273025
C5A51386272976
Table 4 presents the experimental and predicted cancers of miRNA patterns. Column C presents the decision of cancer miRNA with different methods. In Table 4, rows NN1, NN2, and NN3 present the data predicted with the neural network, rows H1, H2, and H3 present the data predicted with the hybrid system, 1-H1, 1-H2, and 1-H3 present the data predicted with the 1-hyper hybrid system, 2-H1, 2-H2, and 2-H3 present the data predicted with the 2-hyper hybrid system, and 10-H1, 10-H2, and 10-H3 present the data predicted with the 10-hyper hybrid system.
Table 4

Experimental and predicted cancers of miRNA patterns.

N D1C1D2C2D3C3C4D4C5D5
E0101010101
NN11000011010
NN21111000111
NN30101000111
H10010111010
H21111110110
H30100001111
1-HH11010111000
1-HH20110000110
1-HH31101000001
2-HH11000111110
2-HH21111111001
2-HH30100000101
10-HH11001111111
10-HH21001000101
10-HH31101010101
The first row is equal to column Y in Table 2, which determines whether the miRNA is cancer or noncancer miRNA. Modeling with NN1 presents a 30% precision from the set of measured data, modeling with NN2 presents a 60% precision from the set of measured data, modeling with NN3 presents a 70% precision from the set of measured data, modeling with H1 presents a 30% precision from the set of measured data, modeling with H2 presents a 30% precision from the set of measured data, modeling with H3 presents a 30% precision from the set of measured data, modeling with 1-HH1 presents a 30% precision from the set of measured data, modeling with 1-HH2 presents a 50% precision from the set of measured data, modeling with 1-HH3 presents a 60% precision from the set of measured data, modeling with 2-HH1 presents a 30% precision from the set of measured data, modeling with 2-HH2 presents a 50% precision from the set of measured data, modeling with 2-HH3 presents a 70% precision from the set of measured data, modeling with 10-HH1 presents a 50% precision from the set of measured data, modeling with 10-HH2 presents a 70% precision from the set of measured data, and modeling with 10-HH3 presents a 90% precision from the set of measured data. Therefore, we can see that 10-HH3 presents the best prediction.

4. Conclusions

In this paper, a novel concept entitled “optimizing the algorithm visibility graph in a 3D space network” is introduced to analyze the relationships between miRNA sequences and the type of cancer miRNA. We have developed a new method for describing the transformation of 1D miRNA sequences into 3D miRNA sequences. Using the topological properties of different types of triads, we have determined miRNA sequences and the difference between cancer and noncancer miRNA. From the results obtained, we are able to conclude that the variation network is a complex network and that it has some dynamic information for further researches. The visibility network in a 3D space, which contains more information than the visibility graph, has been used for the application of miRNA pattern recognition in biomedical engineering. This new method permits to obtain also a physical visualization of the tridimensional miRNA sequences through additively manufactured techniques. Finally, we have built a new type of intelligent system, the n-hyper hybrid system, that can be used for cancer miRNA prediction.
  31 in total

Review 1.  MicroRNAs: a new paradigm on molecular urological oncology.

Authors:  Leonardo Oliveira Reis; Tiago Campos Pereira; Iscia Lopes-Cendes; Ubirajara Ferreira
Journal:  Urology       Date:  2010-05-15       Impact factor: 2.649

2.  microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis.

Authors:  Aaron E Hoffman; Tongzhang Zheng; Chunhui Yi; Derek Leaderer; Joanne Weidhaas; Frank Slack; Yawei Zhang; Trupti Paranjape; Yong Zhu
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

3.  Is the kinetoplast DNA a percolating network of linked rings at its critical point?

Authors:  Davide Michieletto; Davide Marenduzzo; Enzo Orlandini
Journal:  Phys Biol       Date:  2015-05-13       Impact factor: 2.583

4.  Association between miR-125a rs12976445 and survival in breast cancer patients.

Authors:  Lianghe Jiao; Jiaxin Zhang; Yuanyuan Dong; Bensong Duan; Hong Yu; Haihui Sheng; Junxing Huang; Hengjun Gao
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

5.  Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.

Authors:  Irene Catucci; Rongxi Yang; Paolo Verderio; Sara Pizzamiglio; Ludwig Heesen; Kari Hemminki; Christian Sutter; Barbara Wappenschmidt; Michelle Dick; Norbert Arnold; Peter Bugert; Dieter Niederacher; Alfons Meindl; Rita K Schmutzler; Claus C Bartram; Filomena Ficarazzi; Laura Tizzoni; Daniela Zaffaroni; Siranoush Manoukian; Monica Barile; Marco A Pierotti; Paolo Radice; Barbara Burwinkel; Paolo Peterlongo
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

6.  Gene expression-based classification and regulatory networks of pediatric acute lymphoblastic leukemia.

Authors:  Zhigang Li; Wei Zhang; Minyuan Wu; Shanshan Zhu; Chao Gao; Lin Sun; Ruidong Zhang; Nan Qiao; Huiling Xue; Yamei Hu; Shilai Bao; Huyong Zheng; Jing-Dong J Han
Journal:  Blood       Date:  2009-09-15       Impact factor: 22.113

7.  Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women.

Authors:  Zhibin Hu; Jie Liang; Zhanwei Wang; Tian Tian; Xiaoyi Zhou; Jiaping Chen; Ruifen Miao; Yan Wang; Xinru Wang; Hongbing Shen
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

8.  Germline genomic variants associated with childhood acute lymphoblastic leukemia.

Authors:  Lisa R Treviño; Wenjian Yang; Deborah French; Stephen P Hunger; William L Carroll; Meenakshi Devidas; Cheryl Willman; Geoffrey Neale; James Downing; Susana C Raimondi; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Nat Genet       Date:  2009-08-16       Impact factor: 38.330

9.  miR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control study.

Authors:  Zhigang Wang; Meng Wei; Yi Ren; Hua Liu; Meng Wang; Kehui Shi; Hongli Jiang
Journal:  Tumour Biol       Date:  2014-09-12

10.  Gene polymorphisms of micrornas in Helicobacter pylori-induced high risk atrophic gastritis and gastric cancer.

Authors:  Juozas Kupcinskas; Thomas Wex; Alexander Link; Marcis Leja; Indre Bruzaite; Ruta Steponaitiene; Simonas Juzenas; Ugne Gyvyte; Audrius Ivanauskas; Guntis Ancans; Vitalija Petrenkiene; Jurgita Skieceviciene; Limas Kupcinskas; Peter Malfertheiner
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.